Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Amber GibsonCesar NunezLindsay RobustoBrianna KammererMiriam GarciaMichael RothRachna ShethPriti TewariAline HittleLaurie ToepferRomeo TorresNicholas J ShortElias JabbourNitin JainBranko CuglievanDavid McCallPublished in: Haematologica (2024)